Alshimary, N. A. A. H., & Tweij, T.-A. R. (2025). Praliciguat alleviates ferroptosis and inflammation in renal ischemia/reperfusion injury by targeting the AMPK/ACC/PUFA pathway. Babcock University Medical Journal, 8(2), 198–207. https://doi.org/10.38029/babcockuniv.med.j.v8i2.992